Immatics N.V.

IMTXNASDAQHealthcareBiotechnology

$7.15- (-)1Y −25.93%

As of Oct 26, 2026 close

Market cap: $977.26M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $6.65$12.41
Volume (live): -
Avg. volume (3M): 959.26K

Immatics N.V. (IMTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Immatics N.V. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(10 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$17.16

+140.00% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest IMTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 19, 2026	Alec Stranahan	BofA Securities	Maintains	Buy	$17.00
Oct 13, 2026	Laura Prendergast	Stifel Nicolaus	Initiates	Buy	$15.00
Aug 25, 2026	Faisal Khurshid	Jefferies	Reiterates	Buy	$18.00 → $17.00 −1.00 (−5.6%)
Aug 20, 2026	Graig Suvannavejh	Mizuho	Reiterates	Buy	$25.00
Aug 19, 2026	Nicholas Lorusso	TD Cowen	Maintains	Buy	-
Aug 19, 2026	Rajan Sharma	Goldman Sachs	Maintains	Buy	$12.20 → $11.80 −0.40 (−3.3%)
Aug 19, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$17.00
Aug 18, 2026	Nicholas Lorusso	TD Cowen	Maintains	Buy	-
Aug 18, 2026	Rajan Sharma	Goldman Sachs	Maintains	Buy	$12.20 → $11.80 −0.40 (−3.3%)
Aug 18, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$17.00

Alec Stranahan

BofA Securities

BuyMaintains

$17.00

Oct 19

Laura Prendergast

Stifel Nicolaus

BuyInitiates

$15.00

Oct 13

Faisal Khurshid

Jefferies

BuyReiterates

$18.00 → $17.00

Aug 25

Graig Suvannavejh

Mizuho

BuyReiterates

$25.00

Aug 20

Nicholas Lorusso

TD Cowen

BuyMaintains

Aug 19

Rajan Sharma

Goldman Sachs

BuyMaintains

$12.20 → $11.80

Aug 19

Alec Stranahan

BofA Securities

BuyReiterates

$17.00

Aug 19

Nicholas Lorusso

TD Cowen

BuyMaintains

Aug 18

Rajan Sharma

Goldman Sachs

BuyMaintains

$12.20 → $11.80

Aug 18

Alec Stranahan

BofA Securities

BuyReiterates

$17.00

Aug 18

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 19, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IMTX?

The analyst consensus rating for IMTX is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for IMTX?

The average 12-month price target for IMTX is $17.16, representing an upside of 140.0% from the Oct 26, 2026 close of $7.15.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.